NCT07528079 2026-04-16
Organoid-based Sensitivity-guided Chemotherapy for Advanced / Refractory Pediatric Tumors
Shanghai Jiao Tong University School of Medicine
Phase NA Enrolling by invitation
Clinical Trials
96 trialsNCT07533825 2026-04-16
CGCA202501
Tianjin Medical University Cancer Institute and Hospital
Phase NA Enrolling by invitation
NCT06133439 2026-04-14
RISCC
Indiana University
Phase NA Enrolling by invitation
NCT07528963 2026-04-14
KanSurvive 2.0: Testing Enhanced Models of Cancer Survivorship Care for Rural Cancer Survivors in Primary Care Practice
University of Kansas Medical Center
Phase NA Enrolling by invitation
NCT06096220 2026-04-13
Usage of 5-fluorouracil and Carnoy's Solution in Surgical Treatment of Odontogenic Keratocysts
University of Belgrade
Phase 4 Enrolling by invitation
NCT06435312 2026-04-13
ziMyG+
UCB Pharma
Phase 3 Enrolling by invitation
NCT06540144 2026-04-13
An Extension Study Evaluating 6-week Treatment Cycles of Rozanolixizumab in Pediatric Study Participants With Generalized Myasthenia Gravis
UCB Pharma
Phase 3 Enrolling by invitation
NCT06763770 2026-04-13
Digital Self-Management and Peer Mentoring Intervention
Rutgers, The State University of New Jersey
Phase NA Enrolling by invitation
NCT06788509 2026-04-13
A Rollover Study for Continued Study Treatment and Ongoing Safety Monitoring
Janssen Research & Development, LLC
Phase 1 Enrolling by invitation
NCT06940648 2026-04-13
VIABLE
Virtuoso Surgical, Inc.
Phase NA Enrolling by invitation
NCT07296263 2026-04-13
Contrast PMR
Hyperfine
Phase NA Enrolling by invitation
NCT07062354 2026-04-09
CAPT-HN
SWOG Cancer Research Network
Phase 2 Enrolling by invitation
NCT07520214 2026-04-09
Clinical Study on the Safety and Immunogenicity of Specific Cancer Vaccines in Preventing Recurrence of Glioblastoma
Beijing Neurosurgical Institute
Phase EARLY_PHASE1 Enrolling by invitation
NCT00102544 2026-04-08
Use of Tracking Devices to Locate Abnormalities During Invasive Procedures
National Institutes of Health Clinical Center (CC)
Phase NA Enrolling by invitation
NCT05635591 2026-04-08
KSD-101 Therapy for EBV-associated Haematologic Neoplasms: an Exploratory Clinical Trial
Tongji Hospital
Phase 1 Enrolling by invitation
NCT07225920 2026-04-08
PGA
Wake Forest University Health Sciences
Phase NA Enrolling by invitation
NCT07517419 2026-04-08
PIPAC in Gastric Peritoneal Metastasis
Chinese University of Hong Kong
Phase 2 Enrolling by invitation
NCT07517510 2026-04-08
HVA-MPAL
Guangdong Second Provincial General Hospital
Phase 2 Enrolling by invitation
NCT07517666 2026-04-08
GIFTT
Abramson Cancer Center at Penn Medicine
Phase NA Enrolling by invitation
NCT07205783 2026-04-07
Open Radical Prostatectomy Versus Curative Radiotherapy for Treatment of Organ Confined Prostate Cancer (Retrospective Comparative Study)
Sohag University
Phase NA Enrolling by invitation
NCT07514728 2026-04-07
HBOIBCLM
Jinan Central Hospital
Phase NA Enrolling by invitation
NCT02759744 2026-04-06
Fusion Guided Focal Laser Ablation of Prostate Cancer
National Institutes of Health Clinical Center (CC)
Phase NA Enrolling by invitation
NCT05407844 2026-04-06
DeCIDE PC
Wake Forest University Health Sciences
Phase NA Enrolling by invitation
NCT06699615 2026-04-06
Assessing Perceptions of ML Explanations by Medical Oncologists
Abramson Cancer Center at Penn Medicine
Phase NA Enrolling by invitation
NCT06506955 2026-04-03
Futibatinib in Patients Previously Enrolled in an Antecedent Futibatinib as Monotherapy or Combination Therapy.
Taiho Oncology, Inc.
Phase 2/3 Enrolling by invitation
NCT03432936 2026-04-01
Prospective Use of Philips iSuite for Interventional Procedures
Mayo Clinic
Phase NA Enrolling by invitation
NCT06296641 2026-04-01
Cope-CAYAC
Columbia University
Phase NA Enrolling by invitation
NCT06630351 2026-04-01
Group Meaning-Centered Psychotherapy for the Improvement of Wellbeing in Caregivers of Patients With Serious Illness
Mayo Clinic
Phase NA Enrolling by invitation
NCT07503847 2026-03-31
Shared Decision-Making for Colorectal Cancer Screening in High-Risk First-Degree Relatives Aged 40-49
National Taiwan University Hospital
Phase NA Enrolling by invitation
NCT06795126 2026-03-27
Little NIRVANA for Pediatric Pain and Anxiety
Nationwide Children's Hospital
Phase NA Enrolling by invitation
NCT05303532 2026-03-24
ROSY-D
AstraZeneca
Phase 3 Enrolling by invitation
NCT06089954 2026-03-24
ROR
Abramson Cancer Center at Penn Medicine
Phase NA Enrolling by invitation
NCT06763965 2026-03-23
Evaluating the Safety and Efficacy of BioTTT001 in Patients With Recurrent/Progressive High-grade Glioma.
Beijing Bio-Targeting Therapeutics Technology Co., Ltd
Phase 1/2 Enrolling by invitation
NCT07126990 2026-03-23
Clinical Study of a Novel Oncolytic Virus Ad-TD-nsIL12 in the Treatment of Primary High-grade Glioma
Beijing Bio-Targeting Therapeutics Technology Co., Ltd
Phase 1/2 Enrolling by invitation
NCT07218003 2026-03-23
A Phase 1/1b of RNDO-564 Single Agent or in Combination With Pembrolizumab in Bladder Cancer and Other Solid Tumors Associated With Nectin-4
Rondo Therapeutics
Phase 1 Enrolling by invitation
NCT07488312 2026-03-23
LUCENT-GC-01
Qilu Hospital of Shandong University
Phase 1 Enrolling by invitation
NCT07488572 2026-03-23
Safety and Efficacy of Yiwoxidan Anti (AK112) Monotherapy in Patients With Metastatic Renal Clear Cell Carcinoma Who Are Intolerant to TKI Treatment: a Prospective, Single Arm, Phase II Clinical Study
Sun Yat-sen University
Phase 2 Enrolling by invitation
NCT05700461 2026-03-20
Drug Screening Using Novel IMD in Renal Cell Carcinoma
Brigham and Women's Hospital
Phase 1 Enrolling by invitation
NCT05935644 2026-03-19
ORCHID-Miami
University of Miami
Phase NA Enrolling by invitation
NCT07483034 2026-03-19
Receptive Music Therapy Effects on Anxiety, Depression, QoL, and EGF, IL-8, and NfL During the Breast Cancer Treatment.
University of Zagreb
Phase NA Enrolling by invitation
NCT06910475 2026-03-18
DRC_LExS
Catholic University of BrasÃlia
Phase NA Enrolling by invitation
NCT06650748 2026-03-17
NeoMARS
Peking University
Phase 2 Enrolling by invitation
NCT07418437 2026-03-13
Adapting and Pilot Testing a Loneliness Intervention for Cancer Survivors
University of Washington
Phase NA Enrolling by invitation
NCT07465497 2026-03-12
Impact of Supplementation With Synbiotics and Prebiotics on Cognitive Decline Associated With Neoadjuvant Chemotherapy in First-line Patients With Breast Cancer
Instituto Jalisciense de Cancerologia
Phase NA Enrolling by invitation
NCT06191185 2026-03-11
IMPACTT
University of California, San Francisco
Phase NA Enrolling by invitation
NCT05731076 2026-03-10
Self-Management Support for Lung Cancer Patients With Cachexia
Changhua Christian Hospital
Phase NA Enrolling by invitation
NCT06645093 2026-03-10
FasteStudien
University of Oslo
Phase NA Enrolling by invitation
NCT07080463 2026-03-10
VascuLens RCT
University of British Columbia
Phase 1 Enrolling by invitation
NCT06508138 2026-03-06
J21112LINKED
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Phase 1 Enrolling by invitation
NCT06238661 2026-03-05
ProScreenMRI
Fondazione del Piemonte per l'Oncologia
Phase NA Enrolling by invitation